Table 3

Association between EVD epidemic and availability of signal functions at healthcare facilities designated to provide BEmOC or CEmOC

Availability of EmOC signal function (% of month–facility occasions when signal function available)Effect of EVD epidemic
Facility providing BEmOCFacility providing CEmOCAll facilities combined
EmOC signal functionNo Ebola (n=1035)Ebola (n=395)No Ebola (n=207)Ebola (n=79)No Ebola (n=1242)Ebola (n=474)OR (95% CI)p Value
1. im/iv antibiotics95.796.595.793.795.796.01.01 (0.48 to 2.12)0.99
2. im/iv oxytocics94.191.795.292.494.391.80.67 (0.39 to 1.16)0.59
3. im/iv anticonvulsants97.698.095.796.297.397.71.99 (0.71 to 5.57)0.18
4. Manual removal of placenta100.0100.0100.0100.0100.0100.0NV
5. Removal of retained products of conception79.784.3100.0100. (0.71 to 3.83)0.23
6. Assisted vaginal delivery84.481.3100.0100. (0.20 to 1.03)0.056
7. Neonatal resuscitation79.888.477.881.079.587.1NR
8. Blood transfusionNANA91.386.1NANANE
9. Caesarean sectionNANA91.691.6NANANV
  • BEmOC, basic emergency obstetric care; CEmOC, comprehensive emergency obstetric care; EmOC, emergency obstetric care; EVD, Ebola virus disease; im, intramuscular; iv, intravenous; n, number of facility–month combinations; NA, not applicable, signal function not expected at BEmOC facilities; NE, not estimable: in one district the initiation of availability of this signal function coincided with Ebola, in all others there is no variation over months; NV, no variation over time, within each facility, regarding availability of signal function.